Rocket Lab shares jump on earnings date announcement, NASA mission update and Iridium deal approval
Rocket Lab Corp. stock rose 3.9% to $52.87 in pre‑market trading after the company disclosed that it will release its Q3 2026 results on 9 November. The company also said two NASA spacecraft are rehearsing a trans‑Mars injection maneuver, a step it has not completed before. Iridium Communications, the target of Rocket Lab’s roughly $8 billion acquisition, reported Q3 2026 revenue of $245.7 million and EPS of $0.98, and its shareholders approved the deal with 99.6% of votes.
Why it matters
The earnings‑date disclosure gives investors a near‑term catalyst and de‑risks the pending $8 billion Iridium acquisition, which could expand Rocket Lab’s satellite services. Analysts note that the stock’s technical oversold condition and the new NASA mission update may support further upside.
Key facts
- 1Rocket Lab shares advanced 3.9% to $52.87 in pre‑market trading. investing.com
- 2The company announced it will release its third‑quarter 2026 financial results on 9 November after U.S. market close. finance.yahoo.com
- 3Two NASA spacecraft are rehearsing a trans‑Mars injection maneuver, a configuration not previously completed successfully. finance.yahoo.com
- 4Iridium Communications reported Q3 2026 revenue of $245.7 million and earnings of $0.98 per share. finance.yahoo.com
- 5Iridium shareholders approved Rocket Lab’s proposed acquisition with 99.6% of votes cast. finance.yahoo.com
- 6The proposed acquisition of Iridium is valued at approximately $8 billion. finance.yahoo.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.